90Y radiation compared with microwave ablation for small liver cancer
Part of Blood & lymphatic, Cancer, Digestive system clinical trials.
This trial compares two procedures to treat a small, single liver tumor that cannot be surgically removed. It aims to see which treatment works better for people with low blood protein (albumin), which can affect healing and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a liver cancer diagnosis that matches standard liver imaging criteria (LI-RADS) for hepatocellular carcinoma
- Your overall health is good (ECOG score 0 to 1)
- Your liver function is fairly preserved (Child-Pugh A to B) and bilirubin is under 2.5 mg/dL
- Your kidneys are functioning well (creatinine under 2.0 mg/dL)
- You have no prior liver cancer treatments like procedures or medications, and your tumor is one spot (solitary) that is 3 cm or smaller and not removable
- Your albumin (blood protein) is low at diagnosis (below 3.4 g/dL), and the tumor’s location can be treated with either microwave ablation or 90Y radiation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to treat hepatocellular carcinoma (a type of liver cancer): microwave ablation and laparoscopic hepatectomy (keyhole liver surgery). It may help find which option works better for tumor control and recovery in people with limited, non-spread cancer.
This study tests a microwave ablation device to destroy small liver tumors (up to 4 cm) using heat, without major surgery. It is designed for patients with limited disease (1 or 2 tumors) and good liver function.
This study tests a computer-guided microwave ablation procedure to destroy liver tumors. If you have early-stage liver cancer with up to 5 tumors, and one is 2-5 cm in size, you may be a candidate.
This study compares two types of microwave ablation (a heat-based treatment that destroys tumors) with standard surgery for liver cancer tumors that sit near the surface of the liver. The goal is to see which treatment is safer and works better for people whose tumors are close to the liver's outer edge.
This study combines microwave ablation, which uses heat to destroy cancer cells, with immune cell therapy that boosts your body's natural defenses to fight the cancer. It may help people with early-stage liver cancer who cannot have surgery.
This trial tests using a “microwave ablation” procedure to destroy small liver or kidney tumors when surgery isn’t an option or can’t remove everything. It may help patients avoid major surgery by targeting tumors directly with heat.
Hear when a new Carcinoma, Hepatocellular trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.